NEW LONDON, Conn. (WTNH) – A center in southeastern Connecticut is focused on one thing: offering clinical studies, impacting quality of life.
A menopause study to relieve hot flashes is just one of a number of studies at Coastal Connecticut Research Studies in New London.
When women have a hot flash and glisten, the menopausal symptoms are bothersome. “They’ll click a fan on in the middle of the day,” said Jessie Jellison, a clinical research nurse at CCRStudies. “The research we are currently conducting for the hot flashes is to help alleviate the hot flashes and prevent any kind of endometrial growth that goes along with hormone replacement therapy.”
The focus of the research is a drug to increase the level of estrogen, designed to prevent hot flashes. The study, for women between the ages of 40 and 65, is among a half dozen available here.
Dr. Robert Spitz, founder and Medical director, said, “Most of the trials that we do here are on quality-of-life issues. Things that affect a person’s every day life.” The same trials are also done in multiple sites throughout the country.
Women participating in the hot flash study will either get the drug or a placebo. Dr. Spitz pointed out, “The individual woman doesn’t necessarily get benefits from the trial, but the process is necessary to try to get safe and effective medications available.”
There’s also extensive screening, which includes tests they would not otherwise undergo. “We’ve identified a number of people who’ve had conditions that they were not aware of,” Spitz said. “It made it so that they were not eligible to participate in the study, but something was identified that they then had the opportunity to follow up on.”
Women like Kim Gouvin understand the benefit of signing up. “I’m very passionate about health and especially health in women.” Gavin said. “This is the way we can get the study and the drug to progress to become approved.”
Other qualifiers for the hot flash study are women who have not had a hysterectomy and have several hot flashes a day. Other studies underway include studying drugs for endometriosis and multiple sclerosis.
For more information, call 1-860-443-4567 or log onto www.ccrstudies.com.